author-photo

Elad Sharon

National Institutes of Health

152

Papers

3090

Citations

Citation Trend

Filter By

Papers (102) Sort By

Journal Conference Others

Clinical activity of single-agent cabozantinib (XL184), a multi-receptor tyrosine kinase inhibitor, in patients with refractory soft tissue sarcomas.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Atezolizumab Combined with Immunogenic Salvage Chemoimmunotherapy (R-GemOx+Atezo) in Patients with Transformed Diffuse Large B-Cell Lymphoma

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
23 EFFICACY AND SAFETY OF VEDOLIZUMAB AND INFLIXIMAB TREATMENT FOR IMMUNE-MEDIATED DIARRHEA AND COLITIS IN CANCER PATIENTS: A MULTI-CENTER STUDY

2021 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Phase I trial of 5-aza-4’-thio-2’-deoxycytidine (Aza-TdC) in patients with advanced solid tumors.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies.

2021 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Adjuvant pembrolizumab versus interferon alfa-2b or ipilimumab in resected high-risk melanoma.

2021 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (0)
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.

2021 JAMA
Show All
- Source
- Cite
- Save
Citations (24)
SWOG S1609-A phase 2 basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors: A high-grade neuroendocrine neoplasm cohort.

2021 Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute.

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (0)
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (3)